WallStreetZenWallStreetZen

How to Buy Beigene Stock

Beigene Ltd

BeiGene, Ltd. , a biotechnology company, focuses on discovering, developing, manufacturing, and commercializing various medicines worldwide.

Beigene stock last closed at $153.58, up 3.38% from the previous day, and has decreased 37.58% in one year. It has underperformed other stocks in the Biotechnology industry by 0.15 percentage points. Beigene stock is currently +20.96% from its 52-week low of $126.97, and -42.41% from its 52-week high of $266.67.

At the moment, there are 1.36B shares of BGNE outstanding. The market capitalization of BGNE is $16.08B. In the past 24 hours, 208,460 BGNE shares were traded.

How to Buy Beigene Stock

Wondering how to invest in Beigene stock? Here's how.
  1. Choose where to buy Beigene stock: You need to choose an online brokerage, but don't worry - we've tested dozens of online brokerages and apps to help you figure out where to buy Beigene stock.
  2. Create your brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've selected.
  3. Put funds into your investment account: Pick your payment method and add your information.
  4. Evaluate Beigene stock: The Beigene ticker symbol is BGNE. Is Beigene stock a good investment? Should you buy shares of BGNE? How do BGNE's underlying business fundamentals look? Do top analysts think Beigene is a good buy? Why has BGNE's stock price moved recently? (Hint: Our stock analysis website can help you understand if BGNE is a good stock to buy).
  5. Place your BGNE purchase: Decide if you will purchase BGNE shares at the current market price or use a limit order to buy BGNE stock at a specific price.
  6. Monitor your BGNE position: Create a watchlist to get the latest news on your new investment in Beigene shares.

Step 1: Choose where to buy Beigene stock

You will need an online brokerage account in order to access the NASDAQ market and buy BGNE shares.

A brokerage account enables you to buy and sell a variety of financial instruments, including stocks, bonds, mutual funds, and ETFs.

Our favorite brokerage: eToro

Based on our experience, eToro is the best place to buy stocks. eToro gives you:

  • You can invest in stocks with zero commissions: Invest without commissions.
  • Buy fractional shares: Even if you can't afford a full share, you can still purchase the stock.
  • Access to world financial markets: From Tech to Utilities, New York to Hong Kong — you can fill your portfolio with stocks from the world's leading exchanges.
  • Social investing: eToro boasts a community with more than 20 million users around the world. Talk to, learn from, and copy the unique crypto portfolios of other investors.
  • Security: eToro is a regulated and licensed brokerage platform.
  • Buy other financial assets: Such as ETFs and cryptocurrencies.

Get $10 towards your share purchase by opening an account with eToro today.

Open eToro Account
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.

Step 2: Create your brokerage account

Now that you've picked the right brokerage, you need to fill out some personal details so you are able to invest in BGNE stock today.

How to Start a New Account on eToro

  1. Click here to get started.
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
  2. Enter your personal data to open your new trading account.
  1. Send your details by hitting the "Create Account" button.
  2. Get started with eToro today
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 3: Put funds into your investment account

Now that you've created your account on the best stock broker app, your next step is to transfer the money for your investment:

Check out the walkthrough below if you need help depositing funds into your new brokerage account.

Get started with eToro today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 4: Evaluate Beigene stock

After you have figured out the best place to buy Beigene stock, it's very important to evaluate their stock prior to buying, so you truly wrap your head around the risk as well as the upside.

Beigene quick stats

BGNE Price
$153.58
1w %
18.58%
1y %
-37.58%
5y %
27.36%
P/E
-236.28x
P/B
4.54x
P/S
6.52x
PEG
N/A
Revenue
$2.46B
Earnings
-$881.71M
Fore. Rev. Growth
26.07%
Fore. Earn. Growth
N/A
Market Cap
$16.08B
Next Earnings
May 2, 2024
Next Dividend
N/A

Fundamentals of BGNE

WallStreetZen was designed to help part-time investors perform more in-depth fundamental analysis in less time.

You can view all of the due diligence checks on BGNE's stock page.

Is BGNE stock properly valued?

Analysts use many financial metrics, analyses, models, and charts to gauge BGNE's true value.

Using relative valuations methods:

  • BGNE could be undervalued based on its P/B ratio of 4.54x, relative to Biotechnology industry P/B ratio of 5.85x

You can do additional valuation analysis on BGNE's stock here.

BGNE Financial Health

Positive Health Checks:

  • There are more short-term assets than short-term liabilities on the BGNE balance sheet.
  • BGNE has cash burn of 1719349000. It has enough cash and short-term investments to cover this for at least one year.
  • There are more short-term assets than long-term liabilities on the BGNE balance sheet.
  • BGNE has $3.19B in cash and short term investments. This is enough to cover its annual cash burn of $1.72B.

Negative Health Checks:

  • Total BGNE debt is higher than 5 years ago, relative to shareholder equity.
  • BGNE profit margin has gone up by 1.06 percentage points in the past year, but the company is still unprofitable.
  • BGNE has a relatively high debt to equity ratio of 0.64.

Do analysts think it's a good time to buy BGNE stock

Out of 4 Equities analysts who track BGNE, the consensus analyst rating on Beigene is a Strong Buy

Please note that analyst ratings are not recommendations, nor are they financial advice.

You can dig deeper into what analysts are projecting on the Beigene stock forecast page.

BGNE Momentum

SMA10
138.2
SMA20
144.35
SMA50
154.63
SMA100
161.3
SMA200
176.24
MACD
-3.59
MACD Signal
-5.35
MACD Histogram
1.76
RSI
57.06
Stochastic %K
76.7
Stochastic %D
58.39
StochRSI %K
100
StochRSI %D
85.17

BGNE Growth Numbers

Last year, BGNE revenue was $2.46B. In the past 5 year, BGNE's revenue has increased by 65.47% per year. This was faster than the Biotechnology industry average of 28.56%.

You can analyze BGNE's earnings and revenue performance here.

Who is buying/selling BGNE?

In the last 12 months, executives and large shareholders at BGNE have sold more shares than they have bought.

John Oyler, Chief Executive Officer of BGNE, was the latest BGNE insider to sell. They sold $415,305.57 worth of BGNE stock on Apr 11, 2024.

Learn more about who owns BGNE stock here.

Does BGNE provide a stable income stream?

No, Beigene doesn't provide an income stream by paying out dividends.

What others are saying about BGNE

One of the major reasons eToro is our top-rated brokerage is because of its social trading community.

Click below to find out what other traders have to say.

Step 5: Place your BGNE purchase

You have two primary options:

  • Market order: A market order is an order to buy or sell a security at the best possible price.
    Market orders are usually fine.
  • Limit order: A limit order lets you buy or sell a security at a specific price (or better).
    If you want to ensure you're buying or selling at a specific price limit, place a limit order.

Hit the Open button and eToro will execute your order.

If you want more assistance buying stocks on eToro, watch the how to video below:

Open eToro Account

Step 6: Monitor your BGNE position

Now that you own some BGNE shares, you'll want to keep up with your new investment.

Put BGNE on a watchlist to track the latest developments regarding your BGNE stock.

BGNE Feed

How to Buy Stock in Beigene

To summarize, here are the 6 steps to buy stock in Beigene:

  1. Choose where to buy Beigene stock
  2. Create your brokerage account
  3. Put funds into your investment account
  4. Evaluate Beigene stock
  5. Place your BGNE purchase
  6. Monitor your BGNE position

If you are looking for a place to buy stocks, eToro is our favorite option.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

If you want to get updates on your investment in Beigene, click the button below.

NASDAQ: BGNE
$153.58+5.02 (+3.38%)
Updated Apr 26, 2024
Open eToro Account
NASDAQ: BGNE
$153.58+5.02 (+3.38%)
Updated Apr 26, 2024
Open eToro Account

FAQ

How much does it cost to buy one Beigene share?

As of Apr 26, 2024, it costs $153.58 to buy one share of Beigene stock.

Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $100, you can buy 0.651 shares of BGNE.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Is now a good time to buy Beigene stock?

According to 4 Wall Street analysts who monitor Beigene, their consensus recommendation is to buy Beigene stock.

What is the best way to buy Beigene stock?

One way to place an order for Beigene stock is with a brokerage account.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.